I. Frésard, P. Bridevaux, and J. Janssens, “Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis”, Swiss Med Wkly, vol. 141, no. 3334, p. w13240, Aug. 2011.